CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity. - House IG; Derrick EB; Sek K; Chen AXY; Li J; Lai J; Todd KL; Munoz I; Michie J; Chan CW; Huang YK; Chan JD; et al. (Cell reports, 2024)